Evidence method
Level · gp.fundamentals.capex_revenue_ratio
1.57% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
UTMD · Jun 30, 2026
UTAH MEDICAL PRODUCTS INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 4[email protected]
Inspectable configuration
State dimensions
Filing0001096906-26-001210General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
16.22% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
-14.31% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
105.56% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
55.79% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
31.06% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.81% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
0.84% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History29 statesSelf-history eligible
Dec 31, 20217/9 normalizedLevel 3Mar 31, 20227/8 normalizedLevel 3Jun 30, 20227/8 normalizedLevel 3Sep 30, 20228/8 normalizedLevel 3Dec 31, 20228/9 normalizedLevel 3Dec 31, 20228/9 normalizedAmended as filedMar 31, 20238/8 normalizedLevel 3Jun 30, 20238/8 normalizedLevel 3Sep 30, 20238/8 normalizedLevel 3Dec 31, 20238/9 normalizedLevel 3Mar 31, 20248/8 normalizedLevel 3Jun 30, 20248/8 normalizedLevel 3Sep 30, 20248/8 normalizedLevel 3Dec 31, 20248/9 normalizedLevel 3Mar 31, 20258/8 normalizedLevel 3Jun 30, 20258/8 normalizedLevel 3Sep 30, 20258/8 normalizedLevel 3Dec 31, 20258/9 normalizedLevel 3Mar 31, 20268/8 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 1.49%
- Current
- 1.57%
- Delta
- 0.08%
- Previous
- 35.65%
- Current
- 16.22%
- Delta
- -19.43%
- Previous
- -10.18%
- Current
- -14.31%
- Delta
- -4.13%
- Previous
- 100.00%
- Current
- 105.56%
- Delta
- 5.56%
- Previous
- 60.56%
- Current
- 55.79%
- Delta
- -4.77%
- Previous
- 29.41%
- Current
- 31.06%
- Delta
- 1.65%
- Previous
- 1.77%
- Current
- 1.81%
- Delta
- 0.04%
- Previous
- 1.38%
- Current
- 0.84%
- Delta
- -0.53%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
- Similarity
- 84%
- Compared
- 8 dimensions
- Coverage
- 100%
- Similarity
- 80%
- Compared
- 8 dimensions
- Coverage
- 100%
- Similarity
- 78%
- Compared
- 8 dimensions
- Coverage
- 100%
- Similarity
- 77%
- Compared
- 8 dimensions
- Coverage
- 100%
- Similarity
- 66%
- Compared
- 8 dimensions
- Coverage
- 100%
Research Graph
Related governed research
Analogous To · UTMD state analogue 2 →Analogous To · UTMD state analogue 5 →Compared To · Surgical & Medical Instruments & Apparatus peers →Analogous To · UTMD state analogue 3 →Analogous To · UTMD state analogue 1 →Analogous To · UTMD state analogue 4 →Has State · UTAH MEDICAL PRODUCTS INC →Transitioned To · UTMD Fundamental State →Transitioned To · UTMD CAPEX_INTENSITY_INCREASED →Transitioned To · UTMD CASH_GENERATION_DECREASED →Transitioned To · UTMD GROWTH_DECREASED →Transitioned To · UTMD INVENTORY_PRESSURE_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.